1. Centers for Disease Control and Prevention. Genital HPV Infection–CDC Fact
Sheet. Centers for Disease Control and Prevention. 2004.
2. American Cancer society. Cervical cancer. Available at: http//documents. cancer.
org/115.00//115.00.pdf. Accessed July 22, 2005.
3. Прилепская В.И., Кондриков Н.И., Бебнева Т.Н. Значение вирусов папил-
ломы человека в развитии диспластических процессов шейки матки. Ги-
некология. 2000; 2 (3): 33–5.
4. American Cancer society. Prevention & early detection. Available at:
http://www.cancer. Org./docroot/PED-2-3х-Pap-Test.asp. Accessed June 30,
2005.
5. Scheurer ME, Tortolero-Luna G, Adler-Storthz K. Human papillomavirus infection:
biology, epidemiology, and prevention. Intern J Gynecol Cancer 2005; 15
(5): 727–46.
6. Elbasha EH, Galvani AP. Vaccination against multiple HPV types. Math Biosci
2005; 197: 88–117.
7. FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus
to prevent high-grade cervical lesions. N Engl J Med 2007; 356 (19): 1915–27.
8. Mendez F, Munoz N, Posso H et al. Instituto Nacional de Cancerologia Human
Papillomavirus Study Group. Cervical coinfection with human papillomavirus
(HPV) types and possible implications for the prevention of cervical cancer by
HPV vaccines. J Infect Dis 2005; 192: 1158–65.
9. Vandepapeliere P, Barrasso R, Meijer CJ et al. Randomized controlled trial of an
adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external
anogenital warts with multiple HPV types and failure of therapeutic vaccination.
J Infect Dis 2005; 192: 2099–107.
10. Longworth MS, Laimins LA. Pathogenesis of human papillomaviruses in differentiating
epithelia. Microbiology and Molecular Biology Reviews 2004; 68 (2):
362–72.
11. Миченко А.В., Львов А.Н. Возможности местного лечения остроконеч-
ных кондилом. Дерматология. 2009; 2.
12. Миченко А.В., Львов А.Н. Остроконечные кондиломы: особенности
местной терапии. Дерматология. 2009; 1.
13. Kimberlin DW. Current status of antiviral therapy for juvenile-onset recurrent
respiratory papillomatosis. Antiviral Res 2004; 63: 141–51.
14. Baken LA, Koutsky LA, Kuypers J et al. Genital human papillomavirus infection
among male and female sex partners: prevalence and type-specific concordance.
J Infect Dis 1995; 171: 429–32.
15. Wang B, Shao Y, Chung Kuo I Hsueh Ko Hsueh Yuan Hsueh Pao 1994; 16 (2):
122–5.
16. Kinghorn GR, McMillan A, Mulcahy F et al. Int J STD AIDS 1993; 4 (4): 194–9.
17. Александрова Ю.Н., Лыщев А.А., Сафронникова Н.Р. ПВИ у здоровых жен-
щин Санкт-Петербурга. Вопр. онкол. 2000; 6 (2): 175–9.
18. Бебнева Т.Н. Некоторые клинические аспекты папилломавирусной
инфекции. Гинекология. 2007; 9 (1).
19. Бебнева Т.Н., Прилепская В.Н. Папилломавирусная инфекция и пато-
логия шейки матки. Гинекология. 2001; 1 (3): 24–6.
20. Игнатьев Д.В. Борьба с вирусом папилломы человека. Дерматология.
2009; 3.
21. Соловьев А.М. Консервативная терапия поражений, вызванных па-
пилломавирусной инфекцией. Лечащий врач. 2003; 7: 22–6.
22. Genital human papillomavirus infections. Number 19 June 1994. ACOG
technical bulletin. Int J Gynaecol Obstet 1994; 46 (3): 339–45.
23. Von Krogh G, Szpak E, Andersson M et al. Genitourin Med 1994; 70 (2): 105–9.

Ю.Б.Терехова
МСЧ №170, г. Королев